Form 8-K - Current report:
SEC Accession No. 0001193125-25-069748
Filing Date
2025-04-01
Accepted
2025-04-01 08:17:27
Documents
13
Period of Report
2025-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d913876d8k.htm   iXBRL 8-K 34128
  Complete submission text file 0001193125-25-069748.txt   159509

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA phat-20250331.xsd EX-101.SCH 2868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20250331_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20250331_pre.xml EX-101.PRE 11273
15 EXTRACTED XBRL INSTANCE DOCUMENT d913876d8k_htm.xml XML 3646
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

EIN.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 25796718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)